Today, 2K announced King of Kings Edition, Attitude Era Edition, and Monday Night War Edition of WWE® 2K26, the newest ...

Former Michigan football coach Sherrone Moore has pleaded no contest to two misdemeanors in a criminal case that arose ...

A convicted robber who has lived in the North Country and robbed a bank in Merrimack in 2013 faces another stint in prison ...

TOKYO, March 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions ...

COLLEFERRO, IT / ACCESS Newswire / March 6, 2026 / Defense Systems and Solutions (DSS), a joint venture between Yulista ...

Eight years after the EC (European Commission) issued its "yellow card" warning over Illegal, Unreported and Unregulated (IUU ...

Wendy's reports that limited-time offers at restaurants, fueled by FOMO and nostalgia, drive consumer cravings and boost ...

Phase 1 clinical trial of SL-325 ongoing, with data expected in the second quarter of 2026 –Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate ...

Two past critics of the Select Board were elected to join it Tuesday during Town Meeting, signaling a shift in local ...

Abbie Greenleaf Library, built in 1912, is one of Franconia’s jewels in both its architecture and its content. It not only ...

Syntiant, a leading provider of full-stack, low-power embodied AI solutions from sensors to software, today announced it will have a ...

Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis.